Ingredient

Dapagliflozin citric acid

Dapagliflozin citrate is a blood sugar-lowering ingredient used to treat type 2 diabetes.

All medicines
28
Single ingredient
2
Combination
26
Prescription medication
28

MFDS ingredient code M279883

What does it do?

Dapagliflozin citrate belongs to the SGLT2 inhibitor class of diabetes medications. This ingredient is primarily used for blood sugar control in patients with type 2 diabetes. It works by blocking glucose reabsorption in the kidneys, thereby lowering blood sugar levels.

Dapagliflozin citrate inhibits the SGLT2 protein in the kidneys, increasing the amount of glucose excreted in urine. As a result, the concentration of glucose in the blood decreases, and blood sugar is controlled. It acts independently of insulin secretion in the body.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other blood sugar-lowering agents, dapagliflozin citrate does not directly stimulate insulin secretion, resulting in a relatively low risk of hypoglycemia. Additionally, weight loss effects can also be expected, making it useful for the treatment of type 2 diabetes.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

28 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Combined ingredients

Ingredients used together with this ingredient in combination products.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.